Chicago, Illinois | October 5-9, 2024
Taconic Biosciences is going to the SfN Annual Meeting: Neuroscience 2024!
Taconic Biosciences is thrilled to attend SfN to discover new ideas, and support challenges with neuroscience.
How can the right murine model lead to research advancements in your next neuroscience project? Connect with a Taconic scientist to learn more about study-ready cohorts, fully licensed custom model generation, and integrated colony management solutions.
Need a conversation starter? Ask about our comprehensive neuroscience portfolio spanning Alzheimer’s disease, neuropsychiatric disorders, and amyotrophic lateral sclerosis. Taconic also offers several models for use in Parkinson’s disease research sponsored by the Michael J Fox Foundation.
Join Us at SfN: Discover New Neuroscience Research at our Poster Presentation
Interested in learning more? Complete the form to schedule a 1:1 consultation with a neuroscientist at the show. We look forward to learning more about your research needs!
Moriah Jacobson, PhD 
Associate Director, Field Applications Sciences
Dr. Moriah Jacobson joined Taconic Biosciences as a Field Applications Scientist in October 2020, recently transitioning into the role of Associate Director, Field Applications Sciences. She has deep expertise in the development, execution, and review of translational rodent studies. She obtained her Ph.D. in Integrative Neuroscience from Stony Brook University, where she discovered novel biomarkers for several models of chronic stress and chemotherapy-induced cognitive impairment and peripheral neuropathy. She then completed her postdoctoral research at Uniformed Services University where she studied novel rapid acting antidepressant drugs targeting kappa opioid receptors.
How can the right murine model lead to research advancements in your next neuroscience project? Connect with a Taconic scientist to learn more about study-ready cohorts, fully licensed custom model generation, and integrated colony management solutions.
Need a conversation starter? Ask about our comprehensive neuroscience portfolio spanning Alzheimer’s disease, neuropsychiatric disorders, and amyotrophic lateral sclerosis. Taconic also offers several models for use in Parkinson’s disease research sponsored by the Michael J Fox Foundation.
Featured Poster Session
PSTR108 - ALS and Other Motor Neuron Diseases: Animal Models
Sunday, October 6, 2024 | 1:00 PM - 5:00 PM
Inotiv, Inc. | Taconic Biosciences
A transgenic rat expressing the SOD1-G39A mutation exhibits ALS-like phenotypes, rendering it an effective translational model for drug development.
Psychogenics, Inc. | Taconic Biosciences
Characterization of a SOD1 Rat Model of ALS: Behavior and Electrophysiology
Additional Posters
Featuring the Taconic Human 22q11.2 Deletion [Df(h22q11)/+] Mouse
Session PSTR052 - Mechanisms and Therapeutics in Animal Models for Autism
Sunday, October 6, 2024 | 11:00 AM - 12:00 PM
Session: Early Career Poster Session | Poster A61 | Theme A: Development
Characterizing social deficits and potential prosocial effects of D-cycloserine in adolescent Df(h22q11)/+ mice, a model of 22q11.2 Deletion Syndrome
Saturday, October 5, 2024 | 6:30 PM - 8:30 PM
Hall A, McCormick Place Convention Center
Join Us at SfN: Discover New Neuroscience Research at our Poster Presentation
Interested in learning more? Complete the form to schedule a 1:1 consultation with a neuroscientist at the show. We look forward to learning more about your research needs!
Moriah Jacobson, PhD
Associate Director, Field Applications Sciences
Dr. Moriah Jacobson joined Taconic Biosciences as a Field Applications Scientist in October 2020, recently transitioning into the role of Associate Director, Field Applications Sciences. She has deep expertise in the development, execution, and review of translational rodent studies. She obtained her Ph.D. in Integrative Neuroscience from Stony Brook University, where she discovered novel biomarkers for several models of chronic stress and chemotherapy-induced cognitive impairment and peripheral neuropathy. She then completed her postdoctoral research at Uniformed Services University where she studied novel rapid acting antidepressant drugs targeting kappa opioid receptors.
Session PSTR016
Parkinson's Disease: Molecular and Genetic Studies featuring the Taconic LRRK2
Chicago College of Osteopathic Medicine Showcases Neuroscience Research Using Taconic's LRRK2 Transgenic Mouse at SfN 2024
Poster Title: PSTR016.01 / C78 - Effects of Parkinson's Disease on the Neuromuscular Junction of LRRK2 Transgenic Mouse
